How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes
Visitors tour the Nvidia booth during the Nvidia Product Showcase at Computex 2026 in Taipei on June 3, 2026. AFP via Getty Images/I-Hwa Cheng A preprint published June 24, 2026, by 13 researchers at ...
Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.
Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...
Over six weeks in 2024, about 800 senior secondary students in Edo State sat in computer labs twice a week and learned English with the help of Microsoft ...
Integrating humanities into AI development is vital because societal impact is shaped by those who understand meaning, not just builders.
The artificial intelligence giant has hired the former top White House AI adviser and lead author of the White House’s AI ...
Google DeepMind's new report maps four pathways from AGI to artificial superintelligence. Here's how scaling, paradigm shifts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results